Skip to content

Prognosis study of NTM

Correlation of genotype characteristic and clinical prognosis in NTM infected population

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066204
Enrollment
Unknown
Registered
2022-11-28
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nontuberculous mycobacteria infection

Interventions

Case series:none

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years and < 90 years, both male and female; 2. Meet one of the following conditions: NTM microorganism culture positive; NTM - PCR positive; Acid-fast positive or pathological evidence of granuloma +mNGS detection of NTM; 3. Agreed to cooperate with the study process, and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. There are other diseases that may have adverse effects on the safety of subjects or clinical trials; 2. Patients who are deemed unsuitable by the researchers to participate in this clinical study.

Design outcomes

Primary

MeasureTime frame
culture convertion;

Secondary

MeasureTime frame
5-year recurrence rate;5 year mortality;

Countries

China

Contacts

Public ContactMiao Qing

Zhongshan Hospital, Fudan University

sadsadvenus@163.com+8613917763967

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026